Current stock page

News

URGN Stock News

Headlines · Sentiment · Source Context · AIQ Market Impact

HealthcareBiotechnologyScore data as of Nov 13, 2026

URGNUroGen Pharma Ltd.

Healthcare / Biotechnology

Low Priority

In Line With Peers

NeutralEdge 5/10
$26.18−$0.21 (−0.80%)

Latest quote

  • Momentum
    40
  • Value
    64
  • Quality
    68
  • Risk resilience
    40
  • Sentiment
    —
algovestiq.comScore data as of Nov 13, 2026

URGN News

UroGen Pharma Ltd. latest headlines and updates

News Sentiment
No recent news found for URGN
News limit reached for Free plan
Upgrade to Pro for full news feed access and deeper AI insights.
Upgrade to Pro
See how news sentiment affects the AIQ Score
Review news alongside the complete analysis workspace.

URGN News FAQ

What is the latest URGN stock news?

The latest URGN stock news appears on this page when current headlines are available. Use news with price movement, sentiment, AIQ Score, and upcoming catalysts.

Why is URGN stock down today?

URGN's daily move can be affected by earnings, guidance, analyst actions, sector news, macro data, or company-specific headlines. Check the current news feed and sentiment before assigning a cause.

What news is affecting URGN stock today?

News affecting URGN today may include earnings updates, price-target changes, product developments, regulatory items, or sector moves. Confirm whether the news is material or just short-term noise.

What should URGN investors watch next?

URGN investors should watch the next earnings update, analyst revisions, material company news, AIQ momentum, and risk changes. Fresh news matters most when it changes estimates or trend quality.